About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2381-2400 of 4,039 trials

WithdrawnOvarian Damage in Young Premenopausal Women Undergoing Chemotherapy for CancerRATIONALE: Comparing results of diagnostic procedures, such as ultrasound, done before, during, and after chemotherapy may help doctors learn about the side effects of…NCT00402935·Cleveland, Ohio CompletedFenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal CancerPhase II trial to study the effectiveness of fenretinide in treating patients who have recurrent or metastatic ovarian epithelial or primary peritoneal cancer.NCT00026091·Los Angeles, California RecruitingA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsThis is a 2-part, first-in-human, open-label study to determine the safety and tolerability of KIVU-107, a PTK7-directed antibody-drug conjugate, in participants with locally…NCT07229313·Santa Monica, California and 6 others Not yet recruitingFluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian CancerThis is a single-arm, open-label, multicenter exploratory clinical study designed to evaluate the efficacy and safety of fluzoparib combined with famitinib malate as maintenance…NCT07382713

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

RecruitingSequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian CancerThis is a multicenter, open-label Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of sequentially administered CD146-targeted and GPC3-targeted CAR-T cell…NCT07067255·Beijing, Beijing Municipality

CompletedEnapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid TumorsThe purpose of the trial is to determine the maximum tolerated dose and to establish the safety profile of HuMax-AXL-ADC in a mixed population of patients with specified solid…NCT02988817·Phoenix, Arizona and 40 others

RecruitingRegorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian CancerTo see how effective the study medicine combined with hormone therapy is when given to participants with recurrent low-grade serous ovarian cancer.NCT05113368·Cleveland, Ohio

TerminatedA Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid TumorsThis study aims to evaluate the safety, and early signals of anti-tumor activity of PF-07820435 when administered alone (Part 1A) or in combination with sasanlimab (Part 1B; Part…NCT06285097·Sarasota, Florida and 9 others

CompletedEffect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving ChemotherapyTo evaluate whether formal referral to The Symptom Management and Supportive Care Clinic improves symptom burden in advanced stage or recurrent gynecologic oncology chemotherapy…NCT02786524·Ann Arbor, Michigan

CompletedStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerThe primary objective in Phase I is to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent administered in 21-day treatment cycles in…NCT01631552·Aurora, Colorado and 11 others

WithdrawnTo Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian CancerThis is a phase II open label, non-randomized, study to evaluate the safety and efficacy of Ipatasertib (GDC-0068) in combination with paclitaxel in platinum-resistant recurrent…NCT04561817·New York, New York

RecruitingSurvival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian CancerThe purpose of this study is to evaluate the safety and the effectiveness of hepato-celiac lymphadenectomy in the treatment of primarily diagnosed advanced epithelial ovarian…NCT05236686·Shanghai

CompletedExperimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerA Phase I/II study of an in-situ therapeutic cancer vaccine. Vaccines contain a source of antigen and and adjuvant.NCT01065441·Jerusalem

CompletedTaxol Carboplatin and ErythropoetinTime to progression (physical examination and radiologic imagingNCT00158379

CompletedVaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerRATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill the tumor cells.NCT00006041·New York, New York

CompletedTumor Gene Expression in Women With Ovarian CancerThe study objective is to compare changes in expression of glucocorticoid-induced genes that may be involved in cell survival signaling in the tumors of ovarian cancer patients…NCT00817479·Chicago, Illinois

CompletedBRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian CancerPURPOSE: To investigate the prevalence and clinical correlation of the germline BRCA 1/2 mutation in Korean patients with high grade(HG) serous and/or endometrioid epithelial…NCT02963688

WithdrawnIntraperitoneal LSTA1 in CRS-HIPECThis Study is designed to test an investigational product (IP) called LSTA1 (Study drug).NCT06216561·La Jolla, California

WithdrawnCost Utility Analysis in Recurrent Ovarian CancerThe goal of this research study is to learn about the quality of life and sexual functioning of women with platinum-resistant ovarian cancer as they receive other treatments for…NCT00813254·Houston, Texas

Active not recruitingAnlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian CancerIt has been reported that antiangiogenic drugs combined with chemotherapy as first-line treatment, and subsequent antiangiogenic drugs as maintenance therapy for ovarian cancer…NCT04807166·Huai'an and 5 others

PreviousPage 120 of 202Next